首页   >  
Angiogenesis/Protein Tyrosine Kinase
  >  
PDGFR
  • VEGFR
  • FGFR
  >   Orantinib
Orantinib 结构式

Orantinib

参考资料 仅供科学研究,不可用于个人用途。
货号 :BCP01984CAS号 :252916-29-3纯度:98%
全国免运费!免费咨询:400-099-8200 或 手机联系:13472751340
即时询价 ×

* 必填项

请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Inquiry Online ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Bulk Inquiry ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

  • 瀚香生物(Biochempartner)的Orantinib被文献引用
  • 基本信息与产品描述
CAS号 252916-29-3 货号 BCP01984
中文名 Orantinib
英文名 Orantinib
中文别名
英文别名 TSU68; TSU 68; TSU-68; SU6668; SU 6668; SU-6668;
SMILES O=C(O)CCC1=C(C)NC(/C=C2C(NC3=C\2C=CC=C3)=O)=C1C
化学名称
分子式 C18H18N2O3 分子量 310.35
纯度 98% 配送 惯例下常温包邮
产品描述 Orantinib, also known as TSU-68;SU6668, is an orally bioavailable receptor tyrosine kinase inhibitor. Orantinib binds to and inhibits the autophosphorylation of vascular endothelial growth factor receptor 2 (VEGFR2), platelet-derived growth factor receptor (PDGFR), and fibroblast growth factor receptor (FGFR), thereby inhibiting angiogenesis and cell proliferation. Orantinib also inhibits the phosphorylation of the stem cell factor receptor tyrosine kinase c-kit, often expressed in acute myelogenous leukemia cells. Check for active clinical trials or closed clinical trials using this agent.
  • 技术资料和支持
在购买和使用瀚香生物产品的过程中,您遇到的任何问题,都可以咨询我们的免费热线:400-099-8200,或者和我们的客服 。 我们竭诚解决您的一切疑惑,保证您的舒心顺畅。

相关产品推荐

查看更多 >

Tags:Orantinib 供应商,Orantinib 购买,Orantinib 生产,Orantinib 批量,Orantinib 供应,Orantinib 订购,Orantinib 采购

2853530910